speb/financial-data huggingface dataset:
BONE.V income_statement (quarterly, 2024-12-31) — Normalized Income: -228861.00
BONE.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -95987.00
BONE.V income_statement (quarterly, 2024-12-31) — Operating Income: -225327.00
BONE.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 0.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 218599706.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 70793.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 2500471.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 2500.00
BONE.V income_statement (quarterly, 2024-12-31) — Other Gand A: 40656.00
BONE.V income_statement (quarterly, 2024-12-31) — Other Income Expense: -4751.00
BONE.V cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 2915.00
BONE.V income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 163899.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 10949953.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 1668.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Payables: 581100.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 613100.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 0.00
BONE.V income_statement (quarterly, 2024-12-31) — Pretax Income: -233612.00
BONE.V cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 78000.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Receivables: 28554.00
BONE.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 5790.00
BONE.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 5790.00
BONE.V income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: 498.00
BONE.V income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: 498.00
BONE.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -7303.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -30839230.00
BONE.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 0.00
BONE.V income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 14484.00
BONE.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 55638.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 218599706.00
BONE.V cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 0.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 10312655.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 10312655.00
BONE.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 28554.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 11057349.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 10352482.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Total Debt: 131594.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 10312655.00
BONE.V income_statement (quarterly, 2024-12-31) — Total Expenses: 225327.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 744694.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 10969252.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 39827.00
BONE.V income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 2173.00
BONE.V income_statement (quarterly, 2024-12-31) — Total Unusual Items: -4751.00
BONE.V income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -4751.00
BONE.V cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 4760.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Working Capital: -616770.00
BONE.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 206968.00
BONE.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 405419.00
BONE.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 224492010.00
BONE.V income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
BONE.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 57875.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 13510.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 14997.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 39124974.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 31086.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 33169.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 31086.00
BONE.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 432923.00
BONE.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 20111.00
BONE.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -479823.00
BONE.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -245821.00
BONE.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -48986.00
BONE.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: 23012.00
BONE.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -271795.00
BONE.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: -26789.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 39124974.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 10572666.00
BONE.V cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
BONE.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5789.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 64750.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 123697.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 14997.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Current Debt: 72125.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 87122.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 557291.00
BONE.V cash_flow (quarterly, 2025-03-31) — Depreciation: 5789.00
BONE.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5789.00
BONE.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 5789.00
BONE.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 224492010.00
BONE.V income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
BONE.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -216049.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 36000.00
BONE.V income_statement (quarterly, 2025-03-31) — EBIT: -212475.00
BONE.V income_statement (quarterly, 2025-03-31) — EBITDA: -206686.00
BONE.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 31086.00
BONE.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 432923.00
BONE.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -479823.00
BONE.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -457.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2500471.00
BONE.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 22964.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 11046242.00
BONE.V income_statement (quarterly, 2025-03-31) — Gross Profit: -5789.00
BONE.V cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
BONE.V income_statement (quarterly, 2025-03-31) — Interest Expense: 3574.00
BONE.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 3574.00
BONE.V cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 456.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 10684773.00
BONE.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 20111.00
BONE.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 0.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 39982.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 39982.00
BONE.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -7137.00
BONE.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Net Debt: 81021.00
BONE.V income_statement (quarterly, 2025-03-31) — Net Income: -216049.00
BONE.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -216049.00
BONE.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -216049.00
BONE.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -216049.00
BONE.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -216049.00
BONE.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -216049.00
BONE.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -216049.00
BONE.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -3574.00
BONE.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -7137.00
BONE.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -7137.00
BONE.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -3574.00
BONE.V cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -5100.00
BONE.V cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 20111.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 11046242.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 10572666.00
BONE.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -206229.00
BONE.V income_statement (quarterly, 2025-03-31) — Normalized Income: -215592.00
BONE.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -479823.00
BONE.V income_statement (quarterly, 2025-03-31) — Operating Income: -212757.00
BONE.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 227019706.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 72125.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 2500.00
BONE.V income_statement (quarterly, 2025-03-31) — Other Gand A: 22964.00
BONE.V income_statement (quarterly, 2025-03-31) — Other Income Expense: 282.00
BONE.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2647.00
BONE.V income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 739.00
BONE.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 168427.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 11032732.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2083.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Payables: 405419.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 470169.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 48986.00
BONE.V income_statement (quarterly, 2025-03-31) — Pretax Income: -216049.00
BONE.V cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 445160.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Receivables: 41542.00
BONE.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5789.00
BONE.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5789.00
BONE.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -7137.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -31055279.00
BONE.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 15577.00
BONE.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 38541.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 227019706.00
BONE.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 0.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10572666.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 10572666.00
BONE.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 5542.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 11169939.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 10612648.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 127104.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 10572666.00
BONE.V income_statement (quarterly, 2025-03-31) — Total Expenses: 212757.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 597273.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 11046242.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 39982.00
BONE.V income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 2242.00
BONE.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -457.00
BONE.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -457.00
BONE.V cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -415.00
BONE.V balance_sheet (quarterly, 2025-03-31) — Working Capital: -433594.00
BONE.V income_statement (annual, 2025-06-30) — Basic Average Shares: 220541350.00
BONE.V income_statement (annual, 2025-06-30) — Basic EPS: 0.00
BONE.V income_statement (annual, 2025-06-30) — Diluted Average Shares: 220541350.00
BONE.V income_statement (annual, 2025-06-30) — Diluted EPS: 0.00
BONE.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 416694.00
BONE.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 281010.00
BONE.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 240124271.00
BONE.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
BONE.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 96063.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 1930.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2237.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 39912504.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 134615.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 141559.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 134615.00
BONE.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 506951.00
BONE.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -129556.00
BONE.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -338843.00
BONE.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -120294.00
BONE.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 18123.00
BONE.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -2563.00
BONE.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -104734.00
BONE.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: 38552.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 39912504.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 10992336.00
BONE.V cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 535000.00
BONE.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5790.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 43025.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 171712.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2237.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 74832.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 77069.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 401104.00
BONE.V cash_flow (quarterly, 2025-09-30) — Depreciation: 5790.00
BONE.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5790.00
BONE.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5790.00
BONE.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 240124271.00
BONE.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
BONE.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -428026.00
BONE.V income_statement (quarterly, 2025-09-30) — EBIT: -426376.00
BONE.V income_statement (quarterly, 2025-09-30) — EBITDA: -420586.00
BONE.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 134615.00
BONE.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 506951.00
BONE.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -338843.00
BONE.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 1826.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 2787963.00
BONE.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 209939.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 11261441.00
BONE.V income_statement (quarterly, 2025-09-30) — Gross Profit: -5790.00
BONE.V cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
BONE.V income_statement (quarterly, 2025-09-30) — Interest Expense: 1650.00
BONE.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1650.00
BONE.V cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 498.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 11106881.00
BONE.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -129556.00
BONE.V cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 535000.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 39713.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 39713.00
BONE.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -7306.00
BONE.V cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 535000.00
BONE.V income_statement (quarterly, 2025-09-30) — Net Income: -428026.00
BONE.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -428026.00
BONE.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -428026.00
BONE.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -428026.00
BONE.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -428026.00
BONE.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -428026.00
BONE.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -428026.00
BONE.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -7368.00
BONE.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -7306.00
BONE.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -7306.00
BONE.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -7368.00
BONE.V cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -20743.00
BONE.V cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -129556.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 11261441.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 10992336.00
BONE.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -422412.00
BONE.V income_statement (quarterly, 2025-09-30) — Normalized Income: -429852.00
BONE.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -338843.00
BONE.V income_statement (quarterly, 2025-09-30) — Operating Income: -422484.00
BONE.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 248629706.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 74832.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 2500.00
BONE.V income_statement (quarterly, 2025-09-30) — Other Gand A: 20582.00
BONE.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 1826.00
BONE.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 2143.00
BONE.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 184751.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 11259511.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 6944.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Payables: 281010.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 324035.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 18904.00
BONE.V income_statement (quarterly, 2025-09-30) — Pretax Income: -428026.00
BONE.V cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Receivables: 11249.00
BONE.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5790.00
BONE.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5790.00
BONE.V income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 3651.00
BONE.V income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 3651.00
BONE.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -7306.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -31710631.00
BONE.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 185706.00
BONE.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 22004.00
BONE.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 231943.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 248629706.00
BONE.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 185706.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 10992336.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 10992336.00
BONE.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 11249.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 11433153.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 11032049.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 116782.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 10992336.00
BONE.V income_statement (quarterly, 2025-09-30) — Total Expenses: 422484.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 440817.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 11261441.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 39713.00
BONE.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 5718.00
BONE.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1826.00
BONE.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1826.00
BONE.V cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 278.00
BONE.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -229392.00
BONE.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 229332.00
BONE.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 409907.00
BONE.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 248629706.00
BONE.V income_statement (quarterly, 2025-12-31) — Basic EPS: 0.00
BONE.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 134615.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 42656.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 42622.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 39912504.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 38454.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 44010.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 38454.00
BONE.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 45164.00
BONE.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -62456.00
BONE.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -78869.00
BONE.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 130356.00
BONE.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 15123.00
BONE.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -4019.00
BONE.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 141460.00
BONE.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -96161.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 39912504.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 10814780.00
BONE.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
BONE.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 5808.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 22028.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 63059.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 21562.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 76193.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 97755.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 529690.00
BONE.V cash_flow (quarterly, 2025-12-31) — Depreciation: 5808.00
BONE.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5808.00
BONE.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5808.00
BONE.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 248629706.00
BONE.V income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.00
BONE.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -237088.00
BONE.V income_statement (quarterly, 2025-12-31) — EBIT: -235727.00
BONE.V income_statement (quarterly, 2025-12-31) — EBITDA: -229919.00
BONE.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 38454.00
BONE.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 45164.00
BONE.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -78869.00
BONE.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -3100.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2794995.00
BONE.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 47412.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 11342167.00
BONE.V income_statement (quarterly, 2025-12-31) — Gross Profit: -5808.00
BONE.V cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
BONE.V income_statement (quarterly, 2025-12-31) — Interest Expense: 1361.00
BONE.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1361.00
BONE.V income_statement (quarterly, 2025-12-31) — Interest Income: 2513.00
BONE.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2513.00
BONE.V cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 488.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 10930669.00
BONE.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -62456.00
BONE.V cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 21060.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 39696.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 60756.00
BONE.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -7336.00
BONE.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 77435.00
BONE.V income_statement (quarterly, 2025-12-31) — Net Income: -237088.00
BONE.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -237088.00
BONE.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -237088.00
BONE.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -237088.00
BONE.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -237088.00
BONE.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -237088.00
BONE.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -237088.00
BONE.V income_statement (quarterly, 2025-12-31) — Net Interest Income: 1152.00
BONE.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -7336.00
BONE.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -7336.00
BONE.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1152.00
BONE.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 52500.00
BONE.V cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -62456.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 11342167.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 10814780.00
BONE.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -226819.00
BONE.V income_statement (quarterly, 2025-12-31) — Normalized Income: -233988.00
BONE.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -78869.00
BONE.V income_statement (quarterly, 2025-12-31) — Operating Income: -235140.00
BONE.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 248629706.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 76193.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 55000.00
BONE.V income_statement (quarterly, 2025-12-31) — Other Gand A: 36718.00
BONE.V income_statement (quarterly, 2025-12-31) — Other Income Expense: -3100.00
BONE.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 2531.00
BONE.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 161038.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 11299511.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 5556.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Payables: 409907.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 431935.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3781.00
BONE.V income_statement (quarterly, 2025-12-31) — Pretax Income: -237088.00
BONE.V cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Receivables: 15268.00
BONE.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 5808.00
BONE.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5808.00
BONE.V income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 3662.00
BONE.V income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 3662.00
BONE.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -7336.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -31947719.00
BONE.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 7032.00
BONE.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 20882.00
BONE.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 68294.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 248629706.00
BONE.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 7032.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 10814780.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 10814780.00
BONE.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 15268.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 11405226.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 10854476.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 158511.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 10814780.00
BONE.V income_statement (quarterly, 2025-12-31) — Total Expenses: 235140.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 590446.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 11342167.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 60756.00
BONE.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -3100.00
BONE.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3100.00
BONE.V cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 1388.00
BONE.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -466631.00
BONE.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 246708.00
BONE.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 346219.00
BONE.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 254978003.00
BONE.V income_statement (quarterly, 2026-03-31) — Basic EPS: 0.00
BONE.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 38454.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 36840.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 37577.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 40282484.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4685.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9129.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Cash Financial: 4685.00
BONE.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 449463.00
BONE.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -109479.00
BONE.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -373753.00
BONE.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -56740.00
BONE.V cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -77343.00
BONE.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: 3443.00
BONE.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -130640.00
BONE.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: -33769.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 40282484.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 11017915.00
BONE.V cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 506750.00
BONE.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 5816.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 24497.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 102078.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 22518.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Current Debt: 77525.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 100043.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 470759.00
BONE.V cash_flow (quarterly, 2026-03-31) — Depreciation: 5816.00
BONE.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5816.00
BONE.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 5816.00
BONE.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 254978003.00
BONE.V income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.00
BONE.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -260535.00
BONE.V income_statement (quarterly, 2026-03-31) — EBIT: -255946.00
BONE.V income_statement (quarterly, 2026-03-31) — EBITDA: -250130.00
BONE.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 4685.00
BONE.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 449463.00
BONE.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -373753.00
BONE.V income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -3422.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 2913185.00
BONE.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 30329.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Gross PPE: 11441351.00
BONE.V income_statement (quarterly, 2026-03-31) — Gross Profit: -5816.00
BONE.V cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
BONE.V income_statement (quarterly, 2026-03-31) — Interest Expense: 4589.00
BONE.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4589.00
BONE.V cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 515.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 11135136.00
BONE.V cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -109479.00
BONE.V cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 506750.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 15059.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 39696.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 54755.00
BONE.V cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -7328.00
BONE.V cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 506750.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Net Debt: 112536.00
BONE.V income_statement (quarterly, 2026-03-31) — Net Income: -260535.00
BONE.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -260535.00
BONE.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -260535.00
BONE.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -260535.00
BONE.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -260535.00
BONE.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -260535.00
BONE.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -260535.00
BONE.V income_statement (quarterly, 2026-03-31) — Net Interest Income: -4589.00
BONE.V cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -7328.00
BONE.V cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -7328.00
BONE.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4589.00
BONE.V cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -49959.00
BONE.V cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -109479.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 11441351.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 11017915.00
BONE.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -246708.00
BONE.V income_statement (quarterly, 2026-03-31) — Normalized Income: -257113.00
BONE.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -373753.00
BONE.V income_statement (quarterly, 2026-03-31) — Operating Income: -252524.00
BONE.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 258764706.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 77525.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 30500.00
BONE.V income_statement (quarterly, 2026-03-31) — Other Gand A: 21625.00
BONE.V income_statement (quarterly, 2026-03-31) — Other Income Expense: -3422.00
BONE.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 3615.00
BONE.V income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 183458.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Other Properties: 11404511.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 4444.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Payables: 346219.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 370716.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 81124.00
BONE.V income_statement (quarterly, 2026-03-31) — Pretax Income: -260535.00
BONE.V cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Receivables: 11825.00
BONE.V income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 5816.00
BONE.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5816.00
BONE.V income_statement (quarterly, 2026-03-31) — Rent And Landing Fees: 1825.00
BONE.V income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 1825.00
BONE.V cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -7328.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -32208254.00
BONE.V income_statement (quarterly, 2026-03-31) — Salaries And Wages: 6879.00
BONE.V income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 32921.00
BONE.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 63250.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 258764706.00
BONE.V cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 6879.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 11017915.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 11017915.00
BONE.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 11825.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 11543429.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 11057611.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Total Debt: 154798.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 11017915.00
BONE.V income_statement (quarterly, 2026-03-31) — Total Expenses: 252524.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 525514.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 11441351.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 54755.00
BONE.V income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 3257.00
BONE.V income_statement (quarterly, 2026-03-31) — Total Unusual Items: -3422.00
BONE.V income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -3422.00
BONE.V cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 1112.00
BONE.V balance_sheet (quarterly, 2026-03-31) — Working Capital: -368681.00
BONHR.OL balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
BONHR.OL cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -170128000.00
BONHR.OL balance_sheet (annual, 2021-12-31) — Hedging Assets Current: 3163000.00
BONHR.OL cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
BONHR.OL cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
BONHR.OL balance_sheet (annual, 2021-12-31) — Other Equity Interest: 1000.00
BONHR.OL balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 1000.00
BONHR.OL cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
BONHR.OL income_statement (annual, 2021-12-31) — Research And Development: 32000000.00
BONHR.OL income_statement (annual, 2022-12-31) — +Operating Expense: 7712382000.00
BONHR.OL income_statement (annual, 2022-12-31) — +Total Revenue: 11432995000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Accounts Payable: 715904000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Accounts Receivable: 2407631000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -9690335000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 143270000.00
BONHR.OL income_statement (annual, 2022-12-31) — Amortization: 70884000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 70884000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 35911000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 476632000.00
BONHR.OL income_statement (annual, 2022-12-31) — Basic Average Shares: 42531893.00
BONHR.OL income_statement (annual, 2022-12-31) — Basic EPS: 9.30
BONHR.OL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 4039207000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Capital Expenditure: -1040029000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 522044000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Capital Stock: 53165000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4845866000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 4918440000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -182887000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 179104000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Change In Receivables: -554037000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Change In Working Capital: -374933000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Changes In Cash: 1380228000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Common Stock: 53165000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -182887000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 5719092000.00
BONHR.OL income_statement (annual, 2022-12-31) — Cost Of Revenue: 955020000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Current Assets: 8731804000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 86486000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Current Debt: 1302525000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1389011000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Current Liabilities: 4415601000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Deferred Tax: 757529000.00
BONHR.OL balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 78130000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Depreciation: 1017178000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1088062000.00
BONHR.OL income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1088062000.00
BONHR.OL income_statement (annual, 2022-12-31) — Depreciation Income Statement: 1017178000.00
BONHR.OL income_statement (annual, 2022-12-31) — Diluted Average Shares: 42531893.00
BONHR.OL income_statement (annual, 2022-12-31) — Diluted EPS: 9.30
BONHR.OL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 397307000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 25563000.00
BONHR.OL income_statement (annual, 2022-12-31) — EBIT: 2899961000.00
BONHR.OL income_statement (annual, 2022-12-31) — EBITDA: 3988023000.00
BONHR.OL cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 39037000.00
BONHR.OL cash_flow (annual, 2022-12-31) — End Cash Position: 5458472000.00